Your session is about to expire
← Back to Search
Sling
Urethral Sling Surgeries for Stress Urinary Incontinence
Phase 3
Waitlist Available
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Women with stress urinary incontinence with a positive cough test
Be older than 18 years old
Must not have
Previous failed procedure
Voiding dysfunction (PVR>100 mL)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Pivotal Trial
No Placebo-Only Group
Summary
This trial compares two types of surgeries to find out which one is better for women who have trouble controlling their bladder during physical activities. The surgeries help by supporting the bladder or urethra to stop urine leakage.
Who is the study for?
This trial is for women who have stress urinary incontinence confirmed by a cough test and want surgery. It's not suitable for those with mostly overactive bladder symptoms, past unsuccessful treatments, weak urethral closure pressure, significant vaginal prolapse beyond stage 1, or difficulty emptying their bladder fully.
What is being tested?
The study is comparing two surgical procedures to treat female stress urinary incontinence: the Mini-Arc Precise Pro sling and the Trans Vaginal Obturator Tape (TVT-O). Women will be randomly assigned to one of these surgeries.
What are the potential side effects?
Possible side effects from both surgeries may include pain at the incision site, bleeding, infection risk, temporary difficulty urinating post-surgery, and potential injury to surrounding organs during the procedure.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a woman with urine leakage when I cough.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had a treatment or procedure that did not work.
Select...
I have trouble emptying my bladder fully.
Select...
I have a vaginal prolapse more severe than stage 1.
Select...
I mainly have issues with bladder control.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Active Control
Group I: Precise sling vs TVT-O slingActive Control1 Intervention
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for stress incontinence, particularly surgical interventions, aim to improve urethral and bladder neck support. Procedures such as the Trans Vaginal Obturator Tape (TVT-O) and Mini-Arc Precise Pro involve the placement of a supportive mesh or sling under the urethra.
This mesh acts as a hammock, providing additional support to the urethra and bladder neck, which helps to prevent urine leakage during activities that increase abdominal pressure, such as coughing or lifting. These treatments are crucial for stress incontinence patients as they directly address the underlying issue of weakened pelvic floor muscles and connective tissues, thereby significantly improving symptoms and quality of life.
Interventions for treating recurrent stress urinary incontinence after failed minimally invasive synthetic midurethral tape surgery in women.
Interventions for treating recurrent stress urinary incontinence after failed minimally invasive synthetic midurethral tape surgery in women.
Find a Location
Who is running the clinical trial?
University of ManitobaLead Sponsor
621 Previous Clinical Trials
206,563 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a woman with urine leakage when I cough.I have had a treatment or procedure that did not work.Your bladder pressure is less than 20 centimeters of water.I am choosing to have surgery for my condition.I have a vaginal prolapse more severe than stage 1.I have trouble emptying my bladder fully.I mainly have issues with bladder control.
Research Study Groups:
This trial has the following groups:- Group 1: Precise sling vs TVT-O sling
Awards:
This trial has 2 awards, including:- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.